Logotype for H. Lundbeck

H. Lundbeck (LUN) Q3 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for H. Lundbeck

Q3 2026 earnings summary

12 Nov, 2026

Executive summary

  • 9M revenue rose 13% CER (9% DKK) to DKK 20,191m; adjusted EBITDA increased 19% CER to DKK 7,026m, led by Vyepti and Rexulti. Excluding a DKK 470m partner-market inventory build, revenue grew 11% CER and adjusted EBITDA 12% CER.

  • Strong earnings and cash generation supported raised FY 2026 guidance; net debt/EBITDA fell to 0.7x from 1.3x.

Financial highlights

  • 9M gross profit was DKK 16,493m, up 11% CER; gross margin was 81.7% and adjusted gross margin 86.6%, down 2.0 and 1.2 percentage points, respectively.

  • 9M EBIT rose 21% CER (13% DKK) to DKK 5,409m; net profit increased 30% to DKK 4,073m and adjusted net profit rose 25% to DKK 5,369m.

  • 9M adjusted EBITDA margin was 34.8%, up from 33.8%; excluding the inventory-build gross-profit impact, growth was 12% CER and margin was 33.5%.

  • Q3 revenue was DKK 6,603m, up 7% CER; adjusted EBITDA rose 17% CER to DKK 2,261m, with a 34.2% margin. EBIT increased 10% DKK to DKK 1,756m.

  • Q3 gross margin was 82.9% versus 86.5%; adjusted gross margin was 86.6% versus 86.3%.

Outlook and guidance

  • FY 2026 revenue growth guidance rose to 11%–12% CER from 7%–9%; adjusted EBITDA growth guidance rose to 15%–19% CER from 8%–14%.

  • Guidance includes adjusted gross margin of 86%–87%, R&D costs of DKK 5.6–5.7bn, net financial expense of ~DKK 200m and net debt of DKK 4.0–5.0bn.

  • Q4 growth is expected to moderate as the DKK 470m partner inventory build does not recur; U.S. Trintellix generic entry in December and increased Rexulti competition are expected to weigh on growth.

  • 2027 mid-term targets remain mid-single-digit organic revenue CAGR for 2023–2027 and adjusted EBITDA margin above 30%, excluding business development activities; Scale phase priorities include migraine, neuro-rare launches, partnerships and AI capabilities.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from H. Lundbeck